These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 10833475)
1. Azathioprine for maintenance of remission in Crohn's disease: benefits outweigh the risk of lymphoma. Lewis JD; Schwartz JS; Lichtenstein GR Gastroenterology; 2000 Jun; 118(6):1018-24. PubMed ID: 10833475 [TBL] [Abstract][Full Text] [Related]
2. The benefit-to-risk balance of combining infliximab with azathioprine varies with age: a markov model. Scott FI; Vajravelu RK; Bewtra M; Mamtani R; Lee D; Goldberg DS; Lewis JD Clin Gastroenterol Hepatol; 2015 Feb; 13(2):302-309.e11. PubMed ID: 25117775 [TBL] [Abstract][Full Text] [Related]
6. Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid-dependent Crohn's disease. Mantzaris GJ; Christidou A; Sfakianakis M; Roussos A; Koilakou S; Petraki K; Polyzou P Inflamm Bowel Dis; 2009 Mar; 15(3):375-82. PubMed ID: 19009634 [TBL] [Abstract][Full Text] [Related]
7. Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease - a SONIC post hoc analysis. Colombel JF; Reinisch W; Mantzaris GJ; Kornbluth A; Rutgeerts P; Tang KL; Oortwijn A; Bevelander GS; Cornillie FJ; Sandborn WJ Aliment Pharmacol Ther; 2015 Apr; 41(8):734-46. PubMed ID: 25728587 [TBL] [Abstract][Full Text] [Related]
8. Exclusive enteral nutrition with concomitant early thiopurine use was effective in maintaining steroid-free remission in a Southeast Asian cohort of children with Crohn's disease. Ong C; Lim PT; Logarajah V; Liwanag MJ; Ang BX; Cher Y; Chiou FK; Kader A BMC Gastroenterol; 2018 Dec; 18(1):185. PubMed ID: 30541458 [TBL] [Abstract][Full Text] [Related]
9. Impact on Life Expectancy of Withdrawing Thiopurines in Patients with Crohn's Disease in Sustained Clinical Remission: A Lifetime Risk-Benefit Analysis. Kirchgesner J; Beaugerie L; Carrat F; Sokol H; Cosnes J; Schwarzinger M; PLoS One; 2016; 11(6):e0157191. PubMed ID: 27271176 [TBL] [Abstract][Full Text] [Related]
11. Tremor as dose dependent side-effect of azathioprine in remission patient with ileal Crohn's disease. Karaahmet F; Akinci H; Ayte R; Hamamci M; Coskun Y; Yuksel I J Crohns Colitis; 2013 Oct; 7(9):e404. PubMed ID: 23623283 [No Abstract] [Full Text] [Related]
12. Low-dose azathioprine is effective in maintaining remission among Chinese patients with Crohn's disease. Wu J; Gao Y; Yang C; Yang X; Li X; Xiao S J Transl Med; 2013 Sep; 11():235. PubMed ID: 24070341 [TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, controlled withdrawal trial in Crohn's disease patients in long-term remission on azathioprine. Lémann M; Mary JY; Colombel JF; Duclos B; Soule JC; Lerebours E; Modigliani R; Bouhnik Y; Gastroenterology; 2005 Jun; 128(7):1812-8. PubMed ID: 15940616 [TBL] [Abstract][Full Text] [Related]
14. Measurement of red blood cell 6-thioguanine nucleotide is beneficial in azathioprine maintenance therapy of Chinese Crohn's disease patients. Liu Q; Wang Y; Mei Q; Han W; Hu J; Hu N Scand J Gastroenterol; 2016 Sep; 51(9):1093-9. PubMed ID: 27152547 [TBL] [Abstract][Full Text] [Related]
15. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease. Prefontaine E; Macdonald JK; Sutherland LR Cochrane Database Syst Rev; 2009 Oct; (4):CD000545. PubMed ID: 19821270 [TBL] [Abstract][Full Text] [Related]
16. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease. Prefontaine E; Sutherland LR; Macdonald JK; Cepoiu M Cochrane Database Syst Rev; 2009 Jan; (1):CD000067. PubMed ID: 19160175 [TBL] [Abstract][Full Text] [Related]
17. Remission maintained by monotherapy after biological + immunosuppressive combination for Crohn's disease in clinical practice. Ampuero J; Rojas-Feria M; Castro-Fernández M; Millán-Lorenzo M; Guerrero-Jiménez P; Romero-Gómez M J Gastroenterol Hepatol; 2016 Jan; 31(1):112-8. PubMed ID: 26173493 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of azathioprine maintenance therapy in a group of Crohn's disease patients in China. Zheng JJ; Chu XQ; Shi XH; Zhou CL; Seng BW J Dig Dis; 2008 May; 9(2):84-8. PubMed ID: 18419641 [TBL] [Abstract][Full Text] [Related]
20. Predictors of infliximab failure after azathioprine withdrawal in Crohn's disease treated with combination therapy. Oussalah A; Chevaux JB; Fay R; Sandborn WJ; Bigard MA; Peyrin-Biroulet L Am J Gastroenterol; 2010 May; 105(5):1142-9. PubMed ID: 20389296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]